2 μg RNA was used to synthesize single stranded cDNA according to the manufacturer’s instructions. Real time PCR was performed to amplify the cDNA with the TaqMan Universal PCR Master Mix (LC Sciences, USA) as follows: amplification for 30 cycles at 94°C for 0.5 min, annealing at 55°C for 0.5 min, and extension at 72°C for Ion Channel Ligand Library clinical trial 0.5 min; and then terminal elongation step at 72°C for 10 min and a final holding stage at 4°C. The amplification plots were viewed and the baseline and threshold values (as indicated in the instrument user guide) were set to analyze the results. The relative miRNA expression was calculated using 2-ΔΔCt where ΔCt is the difference between target miRNA or reference miRNA Ct values

in the treated and control samples. ΔΔCt is the difference between the above two ΔCt from target miRNA and reference miRNA. Western blotting A549 cells (cultured in 6-well plate at 1.5 × 105 cells per well) were treated with 10 μmol/L bostrycin for 12, 24, 48, and 72 hours, and total proteins were extracted. Protein samples were separated by SDS-PAGE and electrophoretically transferred onto a polyvinylidene difluoride membrane (Millipore, USA). The membrane was blocked overnight at 4 degree in TBS-Tween 20 (TBST) buffer containing 5% skimmed milk powder. The membrane was washed with TBST (3 × 8 minutes). Membranes

were then incubated overnight at 4°C in primary antibody (125 μL/cm3; diluted 1:1,000) with gentle shaking. The membranes were washed with TBST (3 × 8 minutes) and incubated for 1 h at room temperature in HRP-conjugated secondary antibody (125 μL/cm3; see more diluted 1:2,500). The membranes were washed with TBST (3 × 8 minutes) and protein signals were detected by chemiluminescence kit (Cell signaling Technology, USA). Statistical analysis Normally distributed continuous variables were compared by one-way analysis of variance (ANOVA). When a selleck inhibitor significant difference between groups was apparent, multiple comparisons of means were performed using the Bonferroni procedure with type-I error adjustment.

Data are presented as means ± SD. All statistical assessments were two-sided and evaluated at the 0.05 level of significant difference. Statistical analyses were performed using SPSS 13.0 statistics Nintedanib ic50 software (SPSS Inc, Chicago, IL) Results Bostrycin inhibited the proliferation of A549 cells First, we used the MTT assay to detect effect of bostrycin on A549 cell proliferation. There was a dose-dependent and time-dependent inhibition of A549 cell proliferation by bostrycin (Figure 1) with an optimal linear relationship seen between 10-30 μΜ of bostrycin. This indicated that bostrycin could significantly inhibit A549 cell proliferation in vitro. Figure 1 Effect of Bostrycin on the proliferation of A549 cells by MTT assay. A549 cells were treated with 10, 20, or 30 μM of bostrycin for 24 h, 48 h or 72 h.